Second-Order Effects
The numbers you can model are only part of the story.
At Chrystal Clinic, when we built the economic model, we found $42,927 in year-one recoverable revenue. We broke it into five initiatives. We knew the dollar amount attached to each one. The acupuncture repricing was $32,113. The MVP recruitment sprint was $6,978. The retention automations were $3,491. Everything had a number, and the numbers were auditable.
What we did not model was what happens next.
We pushed more patients through their treatment arcs. We re-engaged patients who had been drifting toward lapse. We identified the top revenue generators and started treating them differently. These were the measurable interventions. They had clear inputs and clear outputs and we could track them over time.
But a patient who completes a treatment arc is a different kind of patient afterward. She is more confident in the modality. She has experienced what the treatment was actually designed to do. She refers. She comes back with a new complaint rather than going somewhere else. She becomes, in the language of the model, part of the 6+ cohort, where patients were worth 8.7 times more over their lifetime than someone who visited once.
We had not modeled any of that. We didn't try to. The honest answer is that we weren't sure what to model.
In a different clinic, we recently looked at MVP visit drift as a primary constraint. Active MVPs had reduced their visit frequency materially over four years. The direct calculation was significant, roughly $24,000 per year in lost revenue from patients spacing out rather than lapsing entirely. That number is real and at least partially recoverable through a focused scripting interventions.
But the number in the model is not the only number that changes when you fix the drift.
A patient whose visit frequency is restored is a patient whose treatment is working. That's not a clinical observation, it's an economic one. Patients who are experiencing clinical value return. Patients who are not, drift. When you close the drift, you are not just recovering the revenue from the missing visits. You are extending the lifetime of the relationship. You are resetting the referral probability upward. You are increasing the likelihood that this patient becomes the person who sends two or three others to you over the next decade.
The model did not capture any of that. It captured the direct recovery. The true number, when second-order effects compound, is likely somewhere between 1.5 and 2 times the direct calculation. We say that honestly in our work, and we say it because we have watched it play out.
There is a version of this problem that is easy to name. If you retain a patient who would have lapsed, you get the revenue from the visits she would have missed. That's the first-order effect, and it's the one the model can hold cleanly.
The harder version is the downstream shape of a healthier patient base. A clinic with a stronger retention profile has more referrals because its patients are getting outcomes. It has lower acquisition pressure because more of its growth comes from within. It has a more stable revenue base because it is less dependent on constant new patient flow. These things compound. They are not captured in a one-year calculation.
The embarrassing part, in retrospect, is that when we were running Chrystal on instinct, we weren't thinking about any of this. We were thinking about next week's schedule. The new patient coming in on Tuesday. Whether the slow season would be slow again this year. The economic picture we built later revealed not just what was leaking, but what the shape of the whole thing could have been if we had acted on the signals earlier.
The second-order effects had been accumulating the whole time. We just hadn't been counting them.
The reason this matters for most founders is that the decision economics look different once you account for it.
A retention intervention that costs $8,000 and recovers $14,000 in direct revenue looks like a modest return. That same intervention, when it extends MVP lifetimes, increases referral rates, and shifts the clinic's Acquisition Dependency Index over two years, looks like one of the highest-leverage decisions the business made. The first number is easy to model. The second number requires a different kind of accounting.
What we can say with confidence is that the model almost always understates the value of the intervention. The direct calculation is the floor. The clinics that understand this tend to act on retention findings with more urgency than the direct number warrants, because they know the direct number is incomplete.
The ones that focus only on the floor are still right to act. They're just not fully seeing what they're building.
Finding the measurable leaks in a specific clinic requires looking at that clinic's specific data. The second-order story is real, but it starts with the first-order number, because that's the evidence that the constraint exists and the intervention is worth the cost.
If you don't yet know your visit-1 to visit-2 number, or where your MVP cohort is drifting, those are the questions the model answers first. The compounding comes after.
Luke Bujarski is the founder of LUFT and co-founder of Chrystal Clinic. LUFT builds economic models for cash-pay health clinics. luft.net